NIH is providing a grant opportunity to continue the Preventing Early Renal Loss in Diabetes (PERL) Study by completing participant treatment and analyzing trial outcomes. The study aims to evaluate whether allopurinol can delay kidney disease progression in individuals with type 1 diabetes and early diabetic kidney disease. Closing date for applications is on March 2, 2017.
Opportunity ID: 290398
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DK-16-506 |
Funding Opportunity Title: | Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Food and Nutrition Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 01, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Mar 02, 2017 |
Current Closing Date for Applications: | Mar 02, 2017 |
Archive Date: | Apr 02, 2017 |
Estimated Total Program Funding: | $7,000,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities County governments For profit organizations other than small businesses Independent school districts Special district governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. This FOA is a limited competition for the continuation of the PERL study, which was previously funded under RFA-DK-12-511. Only the currently funded Clinical Research Center (CRC) is eligible to apply. Only the currently funded Biostatistics Research Center (BRC) and clinical sites are eligible to be subcontracts to the CRC. see FOA for Eligibility Details |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to complete treatment of the participants recruited into the Preventing Early Renal Loss in Diabetes (PERL) Study and to analyze the outcomes of the trial. PERL is a randomized, double-blind trial to test whether the medication, allopurinol, can slow the progression of kidney disease in people with type 1 diabetes and early diabetic kidney disease. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-16-506.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00229509 | Feb 02, 2017 | Mar 02, 2017 | View |
Package 1
Mandatory forms
290398 RR_SF424_2_0-2.0.pdf
290398 PHS398_CoverPageSupplement_3_0-3.0.pdf
290398 RR_OtherProjectInfo_1_3-1.3.pdf
290398 PerformanceSite_2_0-2.0.pdf
290398 RR_KeyPersonExpanded_2_0-2.0.pdf
290398 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
290398 RR_Budget_1_3-1.3.pdf
290398 RR_SubawardBudget30_1_3-1.3.pdf
290398 PHS398_ModularBudget_1_2-1.2.pdf
290398 PHS_Inclusion_Enrollment_Report-1.0.pdf
290398 PHS_AssignmentRequestForm-1.0.pdf